Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Evaluating the potential impact of a vaccine on gonorrhoea prevalence in a remote Australian Indigenous setting: a mathematical modelling study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis.
10.1016/s0140-6736(98)90002-2 · 1998 · External reference
HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry.
10.1093/cid/cit437 · 2013 · External reference
Unresolved reference
External reference
The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseases.
10.1136/sti.2004.009431 · 2005 · External reference
Does core area theory apply to sexually transmitted diseases in rural environments?
10.1097/olq.0b013e3182762524 · 2013 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Vaccine value profile for Neisseria gonorrhoeae.
10.1016/j.vaccine.2023.01.053 · 2024 · External reference
Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.
10.1016/j.vaccine.2020.02.073 · 2020 · External reference
Neisseria gonorrhoeae vaccine development: hope on the horizon?
10.1097/qco.0000000000000450 · 2018 · External reference
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.
10.1016/s0140-6736(17)31449-6 · 2017 · External reference
Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: a retrospective study.
10.1016/j.vaccine.2024.126312 · 2024 · External reference
Long-term 4CMenB vaccine effectiveness against gonococcal infection at four years post-program implementation: observational case-control study.
10.1093/ofid/ofae726 · 2025 · External reference
4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation.
10.1016/j.jinf.2023.05.021 · 2023 · External reference
Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study.
10.1016/s1473-3099(21)00754-4 · 2022 · External reference
Meningococcus B vaccination effectiveness against Neisseria gonorrhoeae infection in people living with HIV: a case-control study.
10.1097/olq.0000000000001771 · 2023 · External reference
Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California.
10.1093/cid/ciac436 · 2023 · External reference
Possible impact of wide-scale vaccination against serogroup B Neisseria meningitidis on gonorrhea incidence rates in one region of Quebec, Canada.
10.1093/ofid/ofx180.002 · 2017 · External reference
Association of group B meningococcal vaccine receipt with reduced gonorrhea incidence among university students.
10.1001/jamanetworkopen.2023.31742 · 2023 · External reference
Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study.
10.1016/s1473-3099(21)00812-4 · 2022 · External reference
Meningococcal B vaccine to prevent Neisseria gonorrhoeae infection.
10.1056/nejmoa2516739 · 2026 · External reference
Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO).
10.1038/s41541-026-01422-y · 2026 · External reference
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 x 2 factorial design.
10.1016/s1473-3099(24)00236-6 · 2024 · External reference
Review of mathematical models of Neisseria gonorrhoeae vaccine impact: implications for vaccine development.
10.1016/j.vaccine.2024.03.068 · 2024 · External reference
Unresolved reference
External reference
Incidence of curable sexually transmissible infections among adolescents and young adults in remote Australian Aboriginal communities: analysis of longitudinal clinical service data.
10.1136/sextrans-2014-051617 · 2015 · External reference
Unresolved reference
External reference
Australian gonococcal surveillance programme annual report, 2024.
10.33321/cdi.2025.49.056 · 2025 · External reference
Unresolved reference
External reference
The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting.
10.1016/j.vaccine.2023.07.048 · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: a systematic review and meta-analysis.
10.1016/j.jinf.2024.106225 · 2024 · External reference
An observational study to assess the effectiveness of 4CMenB against meningococcal disease and carriage and gonorrhea in adolescents in the Northern Territory, Australia—study protocol.
10.3390/vaccines10020309 · 2022 · External reference
Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol.
10.1136/bmjopen-2023-079144 · 2024 · External reference
Population movement can sustain STI prevalence in remote Australian indigenous communities.
10.1186/1471-2334-13-188 · 2013 · External reference
